FDA Approved: LUCEMYRA — Supplemental Application (USWM, LLC)

View source ↗

Summary

The FDA approved a supplemental NDA for Lucemyra (lofexidine hydrochloride) submitted by US WorldMeds, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Withdrawal

Drugs mentioned

• LUCEMYRA (LOFEXIDINE HYDROCHLORIDE)

Snippet

SUPPL AP for LUCEMYRA (LOFEXIDINE HYDROCHLORIDE)